Chiome Bioscience
4583.TTSE GROWTHPharmaceutical
Major holders (5%+) · 0
| Holder | Stake |
|---|
No holder currently reports 5% or more.
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| Barclays Bank PLC | 4.30% |
| Growth Capital Inc. | 4.06% |
| Next Growth Inc. | 1.66% |
| Barclays Capital Securities Ltd. | 0.50% |
| Barclays Securities Japan Limited | 0.00% |
Ownership history · 47
| Holder | Ratio | Change |
|---|---|---|
| Growth Capital Inc.2024-07-24 · amended | 6.39% | -0.39pp |
| Next Growth Inc.2024-07-24 · amended | 1.72% | -0.02pp |
| Growth Capital Inc.2024-07-24 · amended | 6.78% | -1.25pp |
| Next Growth Inc.2024-07-24 · amended | 1.74% | -0.03pp |
| Growth Capital Inc.2024-07-24 · amended | 8.03% | -1.12pp |
| Next Growth Inc.2024-07-24 · amended | 1.77% | +0.15pp |
| Growth Capital Inc.2024-07-24 · amended | 9.15% | -1.42pp |
| Next Growth Inc.2024-07-24 · amended | 1.62% | no change |
| Growth Capital Inc.2024-07-24 · amended | 10.57% | -1.15pp |
| Next Growth Inc.2024-07-24 · amended | 1.62% | no change |
| Growth Capital Inc.2024-07-24 · amended | 11.72% | -1.03pp |
| Next Growth Inc.2024-07-24 · amended | 1.62% | no change |
| Growth Capital Inc.2024-07-24 · amended | 12.75% | -0.84pp |
| Next Growth Inc.2024-07-24 · amended | 1.62% | no change |
| Growth Capital Inc.2024-07-24 · amended | 13.59% | -1.09pp |
| Next Growth Inc.2024-07-24 · amended | 1.62% | new |
| Growth Capital Inc.2024-07-24 · amended | 14.68% | +9.93pp |
| Barclays Securities Japan Limited2024-04-05 · amended | 0.00% | no change |
| Barclays Capital Securities Ltd.2024-04-05 · amended | 0.50% | -0.04pp |
| Barclays Bank PLC2024-04-05 · amended | 4.30% | -1.48pp |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.